Study design
The study was approved by the Medical Ethics Committee of the Hangzhou First People's Hospital, affiliated with Zhejiang University, with ethical approval number IIT-20220217–0022, and registration was completed at the China Clinical Trials Registry with registration number ChiCTR2200055835.Written informed consent was obtained from the parents of each patient.